Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05900713
Other study ID # exercises on hypertension
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2023
Est. completion date May 30, 2024

Study information

Verified date December 2023
Source Cairo University
Contact Shimaa Taha Mohamed Taha, ASS.LEC
Phone 01021088610
Email Shimaa.taha395@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Purpose of the study This study will be conducted to investigate any significant effect of dynamic neuromuscular stabilization training on postural control in patients with essential hypertension.


Description:

PURPOSE: This study will be conducted to investigate any significant effect of dynamic neuromuscular stabilization training on postural control in patients with essential hypertension. BACKGROUND: The most recent global estimates suggested that hypertension (HTN) affected 1.13 billion people worldwide. Raised blood pressure (BP) has emerged as the most important risk factor for global morbidity and mortality. Hypertensive individuals present slower processing speed, reduced static and dynamic balance, decreased functional mobility during both single and dual tasking and higher fear of falling in comparison to normotensive individuals. These findings expand the body of knowledge about the effects of HTN on physical functions like prolonged processing time, disturbed balance and reduced mobility functions, which may guide clinicians in including preventive and rehabilitative strategies to their therapy protocols in order to improve the quality of life of the individuals with HTN. HYPOTHESES: Null Hypothesis: there will be no significant effect of dynamic neuromuscular stabilization training on postural control in patients with essential hypertension. RESEARCH QUESTION: Will be any significant effect of dynamic neuromuscular stabilization training on postural control in patients with essential hypertension?


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date May 30, 2024
Est. primary completion date January 1, 2024
Accepts healthy volunteers No
Gender Male
Age group 50 Years to 60 Years
Eligibility Inclusion Criteria: 1. Sixty men patients with stage two essential HTN (more than 140/90 mm hg). 2. Their age will be ranged from 50-60 years old. 3. Body mass index (BMI) from 25 to 34.9 kg/m2. 4. Low levels of physical activity (using the International Physical Activity Questionnaire-Short Version) (The Arabic version of the questionnaire will be used) Exclusion Criteria: 1. Uncontrolled HTN. 2. Diabetes mellitus. 3. Heavy Smoker. 4. Neurological or musculoskeletal conditions that interfere with gait 5. Vertebrobasilar insufficiency (VBI). 6. Use of psychotropic drugs. 7. Impaired vision and/or hearing. 8. Unstable medical conditions. 9. Patients who are unable to follow verbal instructions. 10. Participation in regular exercise training of any type in the previous 3 months.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
dynamic neuromuscular stabilization training
DNS methods demonstrated efficacy in improving global trunk stabilizing patterns with noted gains in extremity movement and strength
balance exercises plus diaphragmatic breathing
The balance exercises is balance exercises while standing and walking The patient assume a semi-Fowler's position and perform diaphragmatic breathing.

Locations

Country Name City State
Egypt Faculty of Physical Therapy Giza
Egypt Faculty of physical therapy Giza

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Ghavipanje V, Rahimi NM, Akhlaghi F. Six Weeks Effects of Dynamic Neuromuscular Stabilization (DNS) Training in Obese Postpartum Women With Low Back Pain: A Randomized Controlled Trial. Biol Res Nurs. 2022 Jan;24(1):106-114. doi: 10.1177/10998004211044828. Epub 2021 Sep 23. — View Citation

Ozaldemir I, Iyigun G, Malkoc M. Comparison of processing speed, balance, mobility and fear of falling between hypertensive and normotensive individuals. Braz J Phys Ther. 2020 Nov-Dec;24(6):503-511. doi: 10.1016/j.bjpt.2019.09.002. Epub 2019 Sep 23. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Postural control by Biodex Balance System The overall stability index (OSI), anteroposterior stability index (APSI), and mediolateral stability index (MLSI) are recorded with a Biodex Balance System, Postural stability test will be performed in the double leg standing position and in the single leg standing position on the right and left legs 8 weeks
Primary balance by The Modified star excursion balance test (mSEBT) • Patients will perform testing while barefoot, maintaining their hands on their hips and a series of single-limb squats using the non-stance limb to touch a point a maximum distance along designated lines on the ground 8 weeks
Primary dynamic balance and functional mobility by Timed-Up-and-Go test (TUG) It uses the time that a person takes to rise from a chair, walk three meters, turn around, walk back to the chair, and sit down while turning 8 weeks
Secondary Sleep quality: using The Pittsburgh Sleep Quality Index (PSQI) It is used to determine self-reported sleep quality and sleep disturbances for the preceding month.
It is a 19-item test and consists of seven components: (1) subjective sleep quality, (2) sleep latency, (3) sleep duration, (4) sleep efficiency, (5) sleep disturbance, (6) sleeping medication use and (7) daytime dysfunction.
8 weeks
Secondary Quality of life: using The 12 Item Short Form Health Survey (SF-12) Questionnaire • The SF-12 consists of 12 questions that examine eight different health domains in order to determine physical and mental health. General Health (GH), Physical Functioning (PF), Role Physical (RP), and Body Pain (BP) are the physical health domains. Vitality (VT), Social Functioning (SF), Role Emotional (RE), and Mental Health (MH) are mental health-related scales 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03708601 - Prognostic Risk of Patients With Essential Hypertension for Cardiovascular Events (PROSPECT)
Not yet recruiting NCT05503953 - Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS Phase 3
Recruiting NCT05526703 - Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy Phase 3
Completed NCT06395194 - Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension Phase 3
Not yet recruiting NCT06418074 - Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity N/A
Completed NCT02890173 - Study of CS-3150 in Patients With Essential Hypertension Phase 3
Completed NCT02944734 - Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension Phase 2
Withdrawn NCT02096939 - Microvascular Function in Primary Aldosteronism N/A
Recruiting NCT01956786 - Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma Homocysteine Phase 2/Phase 3
Completed NCT02553512 - Helius in Hypertension-I: The UK Hypertension Registry N/A
Completed NCT01198249 - Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension Phase 1
Completed NCT01001572 - Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension Phase 3
Recruiting NCT00380289 - Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension N/A
Completed NCT00139698 - Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension Phase 3
Completed NCT00288184 - Uric Acid in Essential Hypertension in Children Phase 2
Completed NCT01289886 - Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects Phase 1
Not yet recruiting NCT06041529 - Study to Evaluate the Efficacy and Safety of TEL/AML/CTD in Elderly Patients With Essential Hypertension Phase 4
Completed NCT04470830 - A Study for PMS of AZL-M/CLD FDC in the Treatment of Participants With Essential HTN in South Korea
Completed NCT00758524 - A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension Phase 2
Recruiting NCT05109013 - Juvenile Essential Arterial Hypertension and Vascular Function